[{"AccountsPayableCurrent_0_Q1_USD":84200000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":47500000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":708100000.0,"OtherLiabilitiesCurrent_0_Q1_USD":7600000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-100000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":500000.0,"RepaymentsOfLinesOfCredit_1_Q1_USD":20000000.0,"ProceedsFromLinesOfCredit_1_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":181700000.0,"RestrictedCashCurrent_0_Q1_USD":200000.0,"RepaymentsOfMediumTermNotes_1_Q1_USD":2800000.0,"TreasuryStockValue_0_Q1_USD":39600000.0,"TreasuryStockShares_0_Q1_shares":1200000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":56200000.0,"AmortizationOfFinancingCosts_1_Q1_USD":700000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.24,"ProceedsFromStockOptionsExercised_1_Q1_USD":9100000.0,"LongTermDebtCurrent_0_Q1_USD":26300000.0,"IncomeTaxesReceivable_0_Q1_USD":10200000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":28200000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-4200000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":17600000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-21300000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-11300000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-23800000.0,"FinitelivedIntangibleAssetsAcquired1_1_Q1_USD":10000000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":1100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":52000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":10100000.0,"OperatingCostsAndExpenses_1_Q1_USD":204100000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":58900000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-14900000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":0.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":5600000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_1_Q1_USD":700000.0,"OtherNoncashIncomeExpense_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1_Q1_USD":2800000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q1_USD":-11200000.0,"OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_1_Q1_USD":0.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":0.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.042,"OperatingLeaseRightOfUseAsset_0_Q1_USD":25600000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":22700000.0,"OperatingLeaseLiability_0_Q1_USD":26900000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"MoneyMarketFundsAtCarryingValue_0_Q1_USD":90700000.0,"LeaseCost_1_Q1_USD":1400000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":114200000.0,"InventoryRawMaterialsAndSuppliesNetOfReserves_0_Q1_USD":77700000.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q1_USD":1100000.0,"FinanceLeaseInterestExpense_1_Q1_USD":300000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q1_USD":3200000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":100000.0,"DeferredFinanceCostsNoncurrentNet_0_Q1_USD":10500000.0,"DeferredCostsCurrent_0_Q1_USD":36300000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":5900000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":85000000.0,"ContractWithCustomerLiability_0_Q1_USD":89400000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":13700000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":26100000.0,"BilledContractReceivables_0_Q1_USD":119400000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":555900000.0,"OtherAssetsNoncurrent_0_Q1_USD":81800000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":192500000.0,"NonoperatingIncomeExpense_1_Q1_USD":-9700000.0,"LongTermDebt_0_Q1_USD":799700000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":41500000.0,"StockholdersEquity_0_Q1_USD":1074800000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":409300000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":549200000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":24100000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":24200000.0,"NetIncomeLoss_1_Q1_USD":-12500000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":57800000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-24200000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-20000000.0,"LiabilitiesCurrent_0_Q1_USD":207100000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":2278700000.0,"Liabilities_0_Q1_USD":1203900000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":800000.0,"InventoryNet_0_Q1_USD":248100000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-108200000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-15600000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-8800000.0,"CommonStockValue_0_Q1_USD":100000.0,"CommonStockSharesOutstanding_0_Q1_shares":52300000.0,"CommonStockSharesIssued_0_Q1_shares":53500000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":181500000.0,"AssetsCurrent_0_Q1_USD":626600000.0,"Assets_0_Q1_USD":2278700000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":700000.0,"AdditionalPaidInCapital_0_Q1_USD":726200000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-21200000.0,"AccountsReceivableNetCurrent_0_Q1_USD":162500000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":15300000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":124000000.0,"Goodwill_0_Q1_USD":266400000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q1_USD":29100000.0,"EarningsPerShareBasic_1_Q1_USD":-0.24,"CostOfGoodsAndServicesSold_1_Q1_USD":76900000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":7300000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-1100000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":708100000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":822100000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1_Q1_USD":700000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":771000000.0,"IncreaseDecreaseInInventories_1_Q1_USD":25600000.0,"IncomeTaxesPaid_1_Q1_USD":3600000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.26,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":63900000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":14800000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":221800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":52000000.0,"ShareBasedCompensation_1_Q1_USD":6600000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":69700000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":42700000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":15000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-11600000.0,"NotesPayableCurrent_0_Q1_USD":26300000.0,"InterestPaidNet_1_Q1_USD":7400000.0,"InterestExpense_1_Q1_USD":8600000.0,"LongTermDebtNoncurrent_0_Q1_USD":762900000.0,"UnbilledContractsReceivable_0_Q1_USD":43100000.0,"Ticker":"EBS","CIK":"1367644","name":"EMERGENT BIOSOLUTIONS INC.","OfficialName":"Emergent Biosolutions Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2077670312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200501"}]